# Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis

> **NCT05810441** · — · COMPLETED · sponsor: **IRCCS Burlo Garofolo** · enrollment: 213 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **OTHER:** Evaluation of diagnostic accuracy of anti-ttg-m

## Key facts

- **NCT ID:** NCT05810441
- **Lead sponsor:** IRCCS Burlo Garofolo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-23
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05810441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05810441, "Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05810441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*